Gosselies, Belgium, 11 September 2025 (08:30 am CET) – Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback